Zobrazeno 1 - 10
of 71
pro vyhledávání: '"H K, Lyu"'
Autor:
Y, Hu, Z, Huang, Y, Wang, H, Liang, X J, Pan, Y P, Chen, L, Yuan, S Y, Yang, J J, Chen, Y Y, Chen, X M, Yan, Q, Tao, X, Qin, H K, Lyu
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 56(11)
To evaluate the safety of the domestic 13-valent pneumococcal polysaccharide conjugate vaccine-tetanus toxoid protein (PCV13-TT) after its licensure. The adverse event following immunization (AEFI) and the vaccination data of PCV13-TT in Zhejiang pro
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 56(11)
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 56(5)
Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis in Asia and the Western Pacific, which mainly invades central nervous system. Vaccination is the most important strategy to prevent JE. Currently, both live att
Publikováno v:
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 43(2)
Estimating the actual real-world effectiveness of the vaccine is an essential part of the post-marketing evaluation. This regression discontinuity design (RDD) using observational data is designed to quantify the effect of an intervention when eligib
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 55(10)
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 54(8)
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 53(7)
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 53(3)
[Post-marketing multi-center safety surveillance of inactivated enterovirus A71 vaccine (Vero cell)]
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 53(3)
Publikováno v:
Extended Abstracts of the 2008 International Conference on Solid State Devices and Materials.